Skip to content
Screener

Ouster OUST Manufacturing Costs

Manufacturing Costs at other companies

Luxfer Holdings logo
Luxfer HoldingsLXFR
$8.6M+3.6%
Luxfer Holdings logo
Luxfer HoldingsLXFR
$200K-33.3%
Flex Ltd. logo
Flex Ltd.FLEX
$695M+9.1%
Flex Ltd. logo
Flex Ltd.FLEX
$758M+10.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$9.09M-39.2%
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
$829K+74.2%

Segments

By segment

See full
Reportable Segment$22.5M+43.0%

Other financials

Income statement

See full
Revenue$48.6M+48.9%
Gross profit$20.8M+54.6%
Operating income-$19.2M+19.4%
Net income-$17.5M+20.7%
EPS (diluted)-$0.28+33.3%

Balance sheet

See full
Cash & equivalents$18.3M-27.3%
Total debt$17.4M-8.3%
Total equity$275.6M+64.1%
Total assets$381.5M+42.0%

Cash flow

See full
Operating cash flow-$7.3M-49.2%
CapEx$2.6M+364%
Free cash flow-$9.8M-81.2%

Valuation

See full
Market cap$3.07B+148%
Enterprise value$3.07B+151%
P/S16.6×+6.7×

Profitability

See full
Gross margin49%+9.5pp
Operating margin-37.9%-13.7pp
Net margin-32.3%-12.1pp
FCF margin-37.4%+11.2pp

Returns & leverage

See full
Return on equity-27%-9.3pp
Debt / equity0.1×0.0×
Current ratio3×+0.4×